Submission Details
| 510(k) Number | K240920 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 04, 2024 |
| Decision Date | July 12, 2024 |
| Days to Decision | 99 days |
| Submission Type | Traditional |
| Review Panel | Gastroenterology & Urology (GU) |
| Summary | Summary PDF |
K240920 is an FDA 510(k) clearance for the HemoCare Bicarbonate Concentrate Set (BCS), a Dialysate Concentrate For Hemodialysis (liquid Or Powder) (Class II — Special Controls, product code KPO), submitted by Deka Research and Development (Manchester, US). The FDA issued a Cleared decision on July 12, 2024, 99 days after receiving the submission on April 4, 2024. This device falls under the Gastroenterology & Urology review panel. Regulated under 21 CFR 876.5820.
| 510(k) Number | K240920 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 04, 2024 |
| Decision Date | July 12, 2024 |
| Days to Decision | 99 days |
| Submission Type | Traditional |
| Review Panel | Gastroenterology & Urology (GU) |
| Summary | Summary PDF |
| Product Code | KPO — Dialysate Concentrate For Hemodialysis (liquid Or Powder) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 876.5820 |